BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » HSCs » Page 30

Hematopoietic Stem Cells (HSCs)

[Featured on MarketResearch.com] 4 Key Metrics You Need to Know to Invest in the Cord Blood Sector

By Leave a Comment

MarketResearch.com has posted an article titled, “4 Key Metrics You Need to Know to Invest in the Cord Blood Sector,” featuring BioInformant’s analytics for the cord blood banking market.

An excerpt is included below: 

“If you are an investor considering an opportunity within the cord blood market, the market can initially appear technical and confusing. However, if you focus on four key metrics, you can quickly and easily assess the technical attributes that matter, including market size, market potential, market competition, and market growth rates.”

Hematopoietic Stem Cell Transplant Rates

A trusted business partner of ours, MarketResearch.com has been selected by Inc. 5000 Magazine as one of America’s fastest growing private companies.

View full post → 

If You’re Investing in the Cord Blood Market, You Need to Know These Metrics [Infographic]

By Leave a Comment

Hematopoietic Stem Cell Transplant Rates, Utilization of Cord Blood, Awareness Rates, and More

The cord blood banking market has emerged gradually over the past 40 years, as 1974 was the first year in which it was proposed that stem and progenitor cells were present in human cord blood.[1]  In the forthcoming years it was established that cord blood stem cells had similar properties as bone marrow and could be used as an alternative.  Because it is a rich source of highly primitive hematopoietic stem cells, umbilical cord blood has enormous regenerative potential for stem cell based therapy, both for the treatment of hematological and non-hematological disorders.
[Read more…]

Cord Blood Industry News Round-Up | March 2015

By Leave a Comment

The cord blood banking industry is a rapidly evolving industry experiencing nearly constant innovation. Every month there are major events that shift industry dynamics. Often, these events are announcements of technical or scientific advancements.  Sometimes they are announcements of industry collaborations or alliances. Occasionally, they are announcements of a new industry competitor, a major milestone, or a significant grant award. [Read more…]

Cord Blood Scientific Publications May Predict What Will Happen in 2015 and Beyond

By Leave a Comment

Trend rate data is valuable for understanding current industry conditions, as well as for predicting future behavior within the cord blood industry.

In upcoming posts, we will be presenting a range of valuable trend rate data, pulled from diverse sources, including grant funding databases, patent databases, clinical trial databases, and more.

In this post, we will begin with an analysis of scientific publication rate data for cord blood industry, because it is an important way to gauge innovation and progress within the marketplace.

Scientific Publication Rate Analysis

PubMed is a service of the U.S. National Library of Medicine and the National Institutes of Health (NIH) that contains citations from MEDLINE and a diverse collection of other life science journals. The data below was generated using the PubMed database, because it is the largest, most comprehensive, and most up-to-date global meta-database available for scientific publications.[1]

It is also the most versatile tool for screening by multiple criteria. [Read more…]

Advantages of Umbilical Cord Blood for Use in HSCT

By Leave a Comment

The stem cells found in cord blood are largely hematopoietic stem cells, which can help in the replenishment of a depleted blood supply by providing new, healthy cells. In the case of certain diseases, such as leukemia, anemia, lymphoma, and others where the blood cells and tissues are severely affected, this replenishment is essential.

There are several important properties of cord blood, including that the number of hematopoietic stem cells in cord blood equals, or exceeds, the frequency of hematopoietic stem cells in bone marrow. In addition, cord blood hematopoietic stem cells can produce large colonies in vitro, have different growth factor requirements, and can be expanded in long-term culture.[1]

Also, cord blood stem cells are characterized as multipotent, because they are capable of differentiating into numerous stem cell types, including neurons, hepatic cells, and circulating cell types.[2]
[Read more…]

BioInformant's World-Class Clients